MeSH term
Frequency | Condition_Probility | Animals | 11 | 0.0 |
Humans | 55 | 0.0 |
B-Lymphocytes | 2 | 1.0 |
Base Sequence | 7 | 0.0 |
Cell Line | 5 | 0.0 |
Molecular Sequence Data | 8 | 0.0 |
Promoter Regions (Genetics)/genetics | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 20 | 0.0 |
Child | 4 | 0.0 |
English Abstract | 8 | 0.0 |
Female | 25 | 0.0 |
Male | 17 | 0.0 |
Odds Ratio | 2 | 0.0 |
Biological Availability | 2 | 0.0 |
Acute Disease | 2 | 0.0 |
Mice | 5 | 0.0 |
Mutation | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 10 | 0.0 |
Amino Acid Sequence | 4 | 0.0 |
Comparative Study | 9 | 0.0 |
Ribosomal Proteins/*genetics | 2 | 2.0 |
Sequence Alignment | 2 | 0.0 |
Sequence Deletion | 2 | 0.0 |
Cyclic AMP-Dependent Protein Kinases/antagonists & inhibitors | 2 | 7.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Phosphodiesterase Inhibitors/pharmacology | 2 | 1.0 |
Tumor Necrosis Factor-alpha/*biosynthesis/genetics | 2 | 2.0 |
Adolescent | 5 | 0.0 |
Adult | 15 | 0.0 |
In Vitro | 3 | 0.0 |
Middle Aged | 19 | 0.0 |
Hydrolysis | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 6 | 0.0 |
Aged | 6 | 0.0 |
Time Factors | 2 | 0.0 |
Prognosis | 2 | 0.0 |
Retrospective Studies | 2 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Binding, Competitive | 3 | 0.0 |
CHO Cells | 2 | 0.0 |
Hamsters | 3 | 0.0 |
Rats | 3 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Zinc Fingers | 2 | 0.0 |
Hela Cells | 2 | 0.0 |
Herpesvirus 4, Human/*genetics | 2 | 2.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Protein Binding | 2 | 0.0 |
Tetradecanoylphorbol Acetate/pharmacology | 2 | 0.0 |
*Taxoids | 2 | 3.0 |
Tumor Cells, Cultured | 4 | 0.0 |
Cells, Cultured | 3 | 0.0 |
Hydrogen-Ion Concentration | 2 | 0.0 |
Child, Preschool | 2 | 0.0 |
Infant | 2 | 0.0 |
Reference Values | 2 | 0.0 |
Cyclic AMP/biosynthesis | 2 | 1.0 |
Receptors, Progesterone/*metabolism | 3 | 2.0 |
Breast Neoplasms/*metabolism | 3 | 1.0 |
Electrophoresis, Polyacrylamide Gel | 3 | 0.0 |
Breast Neoplasms/*analysis | 2 | 5.0 |
Receptors, Progesterone/*analysis | 5 | 2.0 |
Receptors, Estrogen/*analysis | 3 | 1.0 |
Cytosol/analysis | 2 | 6.0 |
